Why the study?
Although SARS-CoV-2 Nsp2 interacts with initiation factor eIF4E2, its role in regulating translation remained controversial.
SARS-CoV-2 Nsp2 stimulates both cap- and IRES-dependent translation under normal and hypoxic conditions, potentially aiding viral replication in patients with poor lung function.
May promote viral protein synthesis in hypoxic tissues; leaves open whether Nsp2-eIF4E2 targeting offers antiviral strategies.
When viruses like SARS-CoV-2 infect cells, they reprogram the repertoire of cellular and viral transcripts that are being translated to optimize their strategy of replication, often targeting host translation initiation factors, particularly eIF4F complex consisting of eIF4E, eIF4G and eIF4A. A proteomic analysis of SARS-CoV-2/human proteins interaction revealed viral Nsp2 and initiation factor eIF4E2, but a role of Nsp2 in regulating translation is still controversial. HEK293T cells stably expressing Nsp2 were tested for protein synthesis rates of synthetic and endogenous mRNAs known to be translated via cap- or IRES-dependent mechanism under normal and hypoxic conditions. Both cap- and IRES-dependent translation were increased in Nsp2-expressing cells under normal and hypoxic conditions, especially mRNAs that require high levels of eIF4F. This could be exploited by the virus to maintain high translation rates of both viral and cellular proteins, particularly in hypoxic conditions as may arise in SARS-CoV-2 patients with poor lung functioning.
No takes yet. Share an insight, caveat, or question.
Korneeva et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: